Literature DB >> 10928499

State of the art: which stent for which lesion in peripheral interventions?

M Henry1, C Klonaris, M Amor, I Henry, K Tzvetanov.   

Abstract

Applications of endovascular procedures have been expanded dramatically throughout the human body for both occlusive and aneurysmal disease; arteries at the aortoiliac and femoropopliteal levels are no exception. Currently, interventional procedures are the 1st treatment option for most patients who have peripheral artery disease. Although balloon angioplasty alone offers good immediate and long-term results, the addition of stents has been proposed to improve the procedural success of angioplasty and extend its application to more patients with vascular disease. Stenting, however, is controversial. Its use is considered acceptable in the aortoiliac vessels but is more in dispute for the femoropopliteal vessels. Moreover, the rapid development of endovascular stents for peripheral applications has made stent selection a complicated task for clinical practitioners. Many factors influence the type of stent selected; therefore, knowledge of the stents available--including various designs and individual properties--is mandatory. Appropriate selection depends on adequate preprocedural evaluation of the lesion; the choice of approach; the choice of primary versus selective stent placement; the location and characteristics of the lesion; the availability of stents in the intervention suite; and the experience of the operator Several stents are now available, but they are not equivalent; it is important to select the stent that is best suited to the lesion. On the basis of our experience using different types of stents, as well as our review of the world medical literature, we summarize the properties of various stents and specific indications for their application. This report is intended for use as a practical guide to stent selection.

Entities:  

Mesh:

Year:  2000        PMID: 10928499      PMCID: PMC101046     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  39 in total

1.  A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions.

Authors:  J Triller; B H Walpoth; P Stirnemann; F Mahler
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

2.  Preliminary observations on the use of the Palmaz stent in the distal portion of the abdominal aorta.

Authors:  E B Diethrich; O Santiago; G Gustafson; R R Heuser
Journal:  Am Heart J       Date:  1993-02       Impact factor: 4.749

3.  Aortic and iliac stenoses: follow-up results of stent placement after insufficient balloon angioplasty in 118 cases.

Authors:  D Vorwerk; R W Günther; K Schürmann; G Wendt
Journal:  Radiology       Date:  1996-01       Impact factor: 11.105

4.  Primary stent placement for chronic iliac artery occlusions: follow-up results in 103 patients.

Authors:  D Vorwerk; R W Guenther; K Schürmann; G Wendt; I Peters
Journal:  Radiology       Date:  1995-03       Impact factor: 11.105

5.  Is percutaneous balloon angioplasty appropriate in the treatment of graft and anastomotic lesions responsible for failing vein bypasses?

Authors:  L A Sanchez; W D Suggs; M L Marin; T F Panetta; K R Wengerter; F J Veith
Journal:  Am J Surg       Date:  1994-08       Impact factor: 2.565

6.  Iliac and femoropopliteal vascular occlusive disease treated with flexible tantalum stents.

Authors:  E P Strecker; B Hagen; D Liermann; B Schneider; H R Wolf; J Wambsganss
Journal:  Cardiovasc Intervent Radiol       Date:  1993 May-Jun       Impact factor: 2.740

7.  The characteristics and anatomic distribution of lesions that cause reversed vein graft failure: a five-year prospective study.

Authors:  J L Mills; R M Fujitani; S M Taylor
Journal:  J Vasc Surg       Date:  1993-01       Impact factor: 4.268

8.  Self-expandable Nitinol stent for cardiovascular applications: canine and human experience.

Authors:  R Beyar; M Henry; R Shofti; E Grenedier; O Globerman; M Beyar
Journal:  Cathet Cardiovasc Diagn       Date:  1994-06

9.  Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4-year follow-up.

Authors:  M Henry; M Amor; G Ethevenot; I Henry; C Amicabile; R Beron; B Mentre; M Allaoui; N Touchot
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

10.  Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis.

Authors:  G Dorros; M Jaff; A Jain; C Dufek; L Mathiak
Journal:  Am J Cardiol       Date:  1995-05-15       Impact factor: 2.778

View more
  5 in total

Review 1.  [PTA and stent placement distal to the superficial femoral artery].

Authors:  T Rand; M Haumer; A Stadler; M Schoder; J Kettenbach
Journal:  Radiologe       Date:  2006-11       Impact factor: 0.635

2.  DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents in the common iliac artery: study protocol for a randomized controlled trial.

Authors:  Joost A Bekken; Jan Albert Vos; Ruud A Aarts; Jean-Paul P M de Vries; Bram Fioole
Journal:  Trials       Date:  2012-11-19       Impact factor: 2.279

3.  Percutaneous transluminal angioplasty of complex aortoiliac occlusive disease secondary to Takayasu's aortoarteritis in a young female.

Authors:  Pankaj Jariwala; Rajendra V Irlapati; Suresh Giragani; Sikandar Shaikh
Journal:  Indian J Radiol Imaging       Date:  2020-10-15

4.  Design of barrier coatings on kink-resistant peripheral nerve conduits.

Authors:  Basak Acan Clements; Jared Bushman; N Sanjeeva Murthy; Mindy Ezra; Christopher M Pastore; Joachim Kohn
Journal:  J Tissue Eng       Date:  2016-02-05       Impact factor: 7.813

5.  Study design and rationale of the 'Balloon-Expandable Cobalt Chromium SCUBA Stent versus Self-Expandable COMPLETE-SE Nitinol Stent for the Atherosclerotic ILIAC Arterial Disease (SENS-ILIAC Trial) Trial': study protocol for a randomized controlled trial.

Authors:  Woong Gil Choi; Seung Woon Rha; Cheol Ung Choi; Eung Ju Kim; Dong Joo Oh; Yoon Hyung Cho; Sang Ho Park; Seung Jin Lee; Ae Yong Hur; Young Guk Ko; Sang Min Park; Ki Chang Kim; Joo Han Kim; Min Woong Kim; Sang Min Kim; Jang Ho Bae; Jung Min Bong; Won Yu Kang; Jae Bin Seo; Woo Yong Jung; Jang Hyun Cho; Do Hoi Kim; Ji Hoon Ahn; Soo Hyun Kim; Ji Yong Jang
Journal:  Trials       Date:  2016-06-25       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.